Wuhan Lin(SH:688667) Shang Hai Zheng Quan Bao·2026-02-27 21:05Financial Performance Summary - The company achieved operating revenue of 1,193.74 million yuan, a slight decrease of 0.17% year-on-year [5] - Operating profit reached 134.80 million yuan, an increase of 1,574.60% year-on-year [5] - Total profit amounted to 134.77 million yuan, showing a year-on-year growth of 1,394.11% [5] - Net profit attributable to shareholders was 134.75 million yuan, up 745.02% year-on-year [5] - The net profit after deducting non-recurring gains and losses was 112.87 million yuan, reflecting a year-on-year increase of 1,602.73% [5] - Basic earnings per share were 2.59 yuan, a rise of 735.48% year-on-year [5] - As of the end of 2025, total assets were 2,208.80 million yuan, an increase of 6.79% year-on-year [5] - Shareholder equity attributable to the parent company was 1,787.63 million yuan, up 10.37% year-on-year [5] - The number of shares increased by 1.71% to 52.70 million shares [5] - Net asset value per share attributable to the parent company was 33.92 yuan, an increase of 8.51% year-on-year [5] Operational Factors - The company maintained steady business operations with breakthroughs in new technologies, products, customers, and projects [6] - Key products such as GECU, ZCU, and integrated solutions have been successfully launched, and self-manufactured injectors have begun mass production [6] - The increase in profit was primarily due to improved profitability of core products and effective cost control measures [6] - Continuous optimization of the supply chain and cost-reduction initiatives in R&D contributed to the improvement in core product profitability [6] - A significant reduction in stock incentive expenses and effective management of R&D costs also supported the growth in operating profit [6]